CAS: 284461-74-1 - 2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-
Fórmula:C20H14ClF3N4O3
InChI:InChI=1S/C20H14ClF3N4O3/c21-16-6-3-12(9-15(16)20(22,23)24)28-19(30)27-11-1-4-13(5-2-11)31-14-7-8-26-17(10-14)18(25)29/h1-10H,(H2,25,29)(H2,27,28,30)
Clave InChI:InChIKey=UAEWBZYTKIMYRQ-UHFFFAOYSA-N
SMILES:O=C(N)C1=NC=CC(OC2=CC=C(C=C2)NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)=C1
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Sorafenib Related Compound 14 REF: 4Z-S-2722CAS: 284461-74-1 | - - - | A consultar | Lun 25 Nov 24 | |
N-Desmethyl Sorafenib REF: TR-D293290CAS: 284461-74-1 | - - - | 264,00 €~1.764,00 € | Vie 29 Nov 24 | |
N-Desmethyl sorafenib REF: 3D-JLA46174CAS: 284461-74-1 | Min. 95% | A consultar | Lun 30 Dic 24 |
Ref: 4Z-S-2722
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
N-Desmethyl Sorafenib
Producto controladoRef: TR-D293290
1g | 1.764,00 € | ||
100mg | 264,00 € |
N-Desmethyl sorafenib
Ref: 3D-JLA46174
250mg | A consultar | ||
500mg | A consultar |